NeuShen Therapeutics
PrivateLast Round
Series B
Sep 3, 2026
Total Funding Raised
$20M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
NeuShen Therapeutics is a biotechnology company that develops innovative therapies for neurological and psychiatric disorders using AAV-based gene therapy and small molecule discovery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuShen Therapeutics Comparables
Compare NeuShen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SciNeuro Pharmaceuticals | 88% | |
| Sensorium Therapeutics | 82% | |
| Zhongze Therapeutics | 79% | |
NeuShen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 3, 2026 | ||||
| Series A Extension | Jan 28, 2026 | ||||
| Series A | Apr 18, 2025 | ||||
| Pre Seed | Sep 29, 2022 |
Key People
Founding team and executive leadership
NeuShen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series A Extension, Series A |
| B Capital Group | Series B |
| Lapam Capital | Series A Extension, Series A, Pre Seed |
| Legend Capital | Series B |
| 上海国投先导私募基金管理有限公司 | Series B |
| TTM Capital | Pre Seed, Series A Extension, Series A |
| MPC | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
$80M round with participation from B Capital Group and Legend Capital.
- Apr 15, 2026
Monthly visitors increased 112% MoM.
NeuShen Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuShen Therapeutics's valuation, stock price, and market status.